132 related articles for article (PubMed ID: 30048825)
1. Therapeutic potential of pancreatic PAX4-regulated pathways in treating diabetes mellitus.
Lorenzo PI; Cobo-Vuilleumier N; Gauthier BR
Curr Opin Pharmacol; 2018 Dec; 43():1-10. PubMed ID: 30048825
[TBL] [Abstract][Full Text] [Related]
2. Targeting protein misfolding to protect pancreatic beta-cells in type 2 diabetes.
Costes S
Curr Opin Pharmacol; 2018 Dec; 43():104-110. PubMed ID: 30245473
[TBL] [Abstract][Full Text] [Related]
3. Compensatory mechanisms of pancreatic beta cells: insights into the therapeutic perspectives for diabetes.
Regazzi R; Dalle S; Abderrahmani A
J Diabetes Res; 2014; 2014():217387. PubMed ID: 25133190
[No Abstract] [Full Text] [Related]
4. The diabetes-linked transcription factor Pax4 is expressed in human pancreatic islets and is activated by mitogens and GLP-1.
Brun T; Hu He KH; Lupi R; Boehm B; Wojtusciszyn A; Sauter N; Donath M; Marchetti P; Maedler K; Gauthier BR
Hum Mol Genet; 2008 Feb; 17(4):478-89. PubMed ID: 17989064
[TBL] [Abstract][Full Text] [Related]
5. PAX4 preserves endoplasmic reticulum integrity preventing beta cell degeneration in a mouse model of type 1 diabetes mellitus.
Mellado-Gil JM; Jiménez-Moreno CM; Martin-Montalvo A; Alvarez-Mercado AI; Fuente-Martin E; Cobo-Vuilleumier N; Lorenzo PI; Bru-Tari E; Herrera-Gómez Ide G; López-Noriega L; Pérez-Florido J; Santoyo-López J; Spyrantis A; Meda P; Boehm BO; Quesada I; Gauthier BR
Diabetologia; 2016 Apr; 59(4):755-65. PubMed ID: 26813254
[TBL] [Abstract][Full Text] [Related]
6. Identifying novel therapeutic targets for diabetes through improved understanding of islet adhesion receptors.
Olaniru OE; Persaud SJ
Curr Opin Pharmacol; 2018 Dec; 43():27-33. PubMed ID: 30086433
[TBL] [Abstract][Full Text] [Related]
7. PAX4 Defines an Expandable β-Cell Subpopulation in the Adult Pancreatic Islet.
Lorenzo PI; Fuente-Martín E; Brun T; Cobo-Vuilleumier N; Jimenez-Moreno CM; G Herrera Gomez I; López Noriega L; Mellado-Gil JM; Martin-Montalvo A; Soria B; Gauthier BR
Sci Rep; 2015 Oct; 5():15672. PubMed ID: 26503027
[TBL] [Abstract][Full Text] [Related]
8. Pax4 in Health and Diabetes.
Ko J; Fonseca VA; Wu H
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175989
[TBL] [Abstract][Full Text] [Related]
9. Editorial overview: Endocrine and metabolic diseases Druggable diabetes: identification of therapeutic opportunities.
Persaud SJ; Bowe JE
Curr Opin Pharmacol; 2018 Dec; 43():iii-v. PubMed ID: 30446351
[No Abstract] [Full Text] [Related]
10. Inflammatory stress in islet β-cells: therapeutic implications for type 2 diabetes?
Lytrivi M; Igoillo-Esteve M; Cnop M
Curr Opin Pharmacol; 2018 Dec; 43():40-45. PubMed ID: 30142486
[TBL] [Abstract][Full Text] [Related]
11. Antidiabetic potential of saffron and its active constituents.
Yaribeygi H; Zare V; Butler AE; Barreto GE; Sahebkar A
J Cell Physiol; 2019 Jun; 234(6):8610-8617. PubMed ID: 30515777
[TBL] [Abstract][Full Text] [Related]
12. Glucagon-like peptide 1-potentiated insulin secretion and proliferation of pancreatic β-cells.
Ma X; Guan Y; Hua X
J Diabetes; 2014 Sep; 6(5):394-402. PubMed ID: 24725840
[TBL] [Abstract][Full Text] [Related]
13. Induction of multiple cycles of pancreatic β-cell replacement.
Pfeifer A; Courtney M; Ben-Othman N; Al-Hasani K; Gjernes E; Vieira A; Druelle N; Avolio F; Faurite B; Mansouri A; Collombat P
Cell Cycle; 2013 Oct; 12(20):3243-4. PubMed ID: 24036539
[No Abstract] [Full Text] [Related]
14. Adult duct-lining cells can reprogram into β-like cells able to counter repeated cycles of toxin-induced diabetes.
Al-Hasani K; Pfeifer A; Courtney M; Ben-Othman N; Gjernes E; Vieira A; Druelle N; Avolio F; Ravassard P; Leuckx G; Lacas-Gervais S; Ambrosetti D; Benizri E; Hecksher-Sorensen J; Gounon P; Ferrer J; Gradwohl G; Heimberg H; Mansouri A; Collombat P
Dev Cell; 2013 Jul; 26(1):86-100. PubMed ID: 23810513
[TBL] [Abstract][Full Text] [Related]
15. PAX4 R192H and P321H polymorphisms in type 2 diabetes and their functional defects.
Sujjitjoon J; Kooptiwut S; Chongjaroen N; Semprasert N; Hanchang W; Chanprasert K; Tangjittipokin W; Yenchitsomanus PT; Plengvidhya N
J Hum Genet; 2016 Nov; 61(11):943-949. PubMed ID: 27334367
[TBL] [Abstract][Full Text] [Related]
16. Past and current perspective on new therapeutic targets for Type-II diabetes.
Patil PD; Mahajan UB; Patil KR; Chaudhari S; Patil CR; Agrawal YO; Ojha S; Goyal SN
Drug Des Devel Ther; 2017; 11():1567-1583. PubMed ID: 28579755
[TBL] [Abstract][Full Text] [Related]
17. The Diabetes-Linked Transcription Factor PAX4: From Gene to Functional Consequences.
Lorenzo PI; Juárez-Vicente F; Cobo-Vuilleumier N; García-Domínguez M; Gauthier BR
Genes (Basel); 2017 Mar; 8(3):. PubMed ID: 28282933
[TBL] [Abstract][Full Text] [Related]
18. Inactivating the permanent neonatal diabetes gene Mnx1 switches insulin-producing β-cells to a δ-like fate and reveals a facultative proliferative capacity in aged β-cells.
Pan FC; Brissova M; Powers AC; Pfaff S; Wright CV
Development; 2015 Nov; 142(21):3637-48. PubMed ID: 26534984
[TBL] [Abstract][Full Text] [Related]
19. Ectopic expression of
Druelle N; Vieira A; Shabro A; Courtney M; Mondin M; Rekima S; Napolitano T; Silvano S; Navarro-Sanz S; Hadzic B; Avolio F; Rassoulzadegan M; Schmid HA; Mansouri A; Collombat P
J Cell Biol; 2017 Dec; 216(12):4299-4311. PubMed ID: 29025873
[TBL] [Abstract][Full Text] [Related]
20. Glucagon-Like Peptide 1 Analogs and their Effects on Pancreatic Islets.
Tudurí E; López M; Diéguez C; Nadal A; Nogueiras R
Trends Endocrinol Metab; 2016 May; 27(5):304-318. PubMed ID: 27062006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
